ARCHIVES

Cancer Advocates Seek 6.5% Increase For NCI In Fiscal 1997

This article is from The Cancer Letter archive.

Vol. 22 No. 10 | March 8, 1996

Download PDF Visit The Full Archive

Related Articles

ASCO: Anastrozole Adds Treatment Option, But Tamoxifen Remains Standard

September 13, 2002

Major Changes In NCI Drug screening Tumor Panels Approved

June 18, 1982

In Brief: NCI to Extend Frederick contract To SAIC; Klausner, Gallin, Gail Elected to IOM

October 24, 1996

Iressa Just As Effective As Chemotherapy For Second-Line Therapy, Study Finds

November 28, 2008

NCI CTEP-Approved Trials For the Month of December

December 26, 2014

Masons Give $65 Million to Univ. of Minnesota Cancer Center.

April 25, 2008